Rx Branded Pharmaceuticals
Prescription pharmaceuticals is a massive global industry, with the top 200 prescription products amassing worldwide sales of $248.9 billion in 2004, up from $218.7 billion in 2003. There are high barriers to both entry and continued viability in the industry, because of competition and the need for constant product innovation. While the pharmaceutical industry generates physically tangible products, it is very much knowledge-based. Companies compete on their ability to add value through the creation and exploitation of knowledge rather than factory-like manufacturing efficiency (the latter being the basis of competition for generic manufacturers).
Technology Catalysts realizes that pharmaceutical companies of all tiers are pressured to continually innovate, increase growth, and accelerate time to market, while also maintaining quality and increasing efficiency. With over two decades of consulting experience, TCI has assisted numerous pharmaceutical companies by providing custom consulting to suit their individual needs.
